Background
==========

Rapid and reliable diagnosis is one of the key factors in promoting malaria control. The gold standard for malaria diagnosis remains the examination of Giemsa-stained smears by light microscopy. Whilst this standard has a good sensitivity and specificity and allows species and stage differentiation, it does require the expertise of a trained and experienced microscopist, is time-consuming (30 minutes per diagnostic) and requires equipment not always available or maintainable in remote areas. The 1990\'s have seen the advent of a new rapid diagnostic method, the immunochromatography-based malaria Rapid Diagnostic Tests (RDTs). These assays are fast (revealed in 15 minutes) and, for the most part, very simple to use. Moreover with the change of therapeutic practice towards relatively expensive artemisinin-based combination therapies \[[@B1]\], a good diagnostic has become essential to limit inappropriate treatment and the development of resistance. Although the use of RDTs has spread, their reliability is still questioned in numerous studies \[[@B2],[@B3]\]. These assays detect one or several antigens, the most common are: histidine-rich protein-2 (HRP-2), aldolase and lactate dehydrogenase (pLDH).

Lactate dehydrogenase is an enzyme that catalyzes the inter-conversion of lactate into pyruvate. This enzyme is essential for energy production in *Plasmodium*\[[@B4]\]. The level of pLDH in the blood has been directly linked to the level of parasitaemia \[[@B5]\].

The genetic diversity of HRP2 has been examined and partly linked to RDT detection sensitivity \[[@B6]\], the genetic variability has also been assessed in aldolase, it has been ruled out as a possible cue for variation RDT sensitivity \[[@B7]\]. Here is the first study of *Plasmodium*LDH genetic variability as a possible cause of variation in sensitivity of RDTs.

Methods
=======

A total of eight *Plasmodium*species (*Plasmodium falciparum, Plasmodium vivax, Plasmodium. ovale, Plasmodium malariae, Plasmodium yoeli, Plasmodium chabaudi, Plasmodium berghei and Plasmodium. reichnowi*), including the four human pathogens, from numerous origins (Figure [1](#F1){ref-type="fig"}) were examined with a nested-PCR assay amplifying a 543 bp fragment: corresponding to the 57 to 237 amino acid position of the reference *P. falciparum*LDH coding sequence (pf13_0141). All field samples analysed were diagnosed by microscopic examination and confirmed by PCR \[[@B8]\] and conserved from previous studies and approved at the time by respective National Ethics Committees. Two sets of PCR and nested primers were designed for this study based on the sequences available on GenBank (Table [1](#T1){ref-type="table"}) one set use for *P. vivax*and *P. falciparum*, and the other for *P. ovale*and *P. malariae*.

![Worldwide distribution of the isolate sequenced in the study, grouped by species. One dot corresponds to one isolate, in red the malaria endemic area.](1475-2875-6-140-1){#F1}

###### 

PCR and nested-PCR primers used in the study

  PCR primers      Primer sequence 5\' to 3\'
  ---------------- ----------------------------
  Fv1              ATGATYGGAGGMGTWATGGC
  Fv2              GCCTTCATYCTYTTMGTYTC
  Mo1              ATGATWGGAGGTGTTATGGC
  Mo2              TGTGTCCRTATTGDCCTTC
  Nested Primers   
  Fv1n             AATGTKATGGCWTATTCMAATTGC
  Fv2n             AACRASAGGWGTACCACC
  Mo1n             TAGGMGATGTTGTTATGTTYG
  Mo2n             ATTTCRATAATAGCAGCAGC

Forty PCR cycle were undertaken using 94°C for 30 s, 55°C for 60 s and 72°C for 75 s; the same cycle was used for the nested-PCR but only repeated 35 times. Positive and negative controls were included in all amplification assays. The amplified products were purified using a Quiaquick PCR purification kit (QIAGEN, Valencia, CA) according to the manufacturer\'s recommendations, and sequenced using Big Dye Terminator kit v1.1 (Applied Biosystems, Foster City, CA) in an AbiPrism 3130 sequencing machine (Applied Biosystems, Foster City, CA).

Results
=======

No variability was observed in *P. falciparum*(n = 49) with a homology of 100% between all newly sequenced sequences (named F). A single reference sequence on GenBank (corresponding to the FCC1/HN strain) exhibited a different amino acid sequence (named F1). For *P. vivax*(n = 10), four different types of sequence were found, the mutations observed were all synonymous (named V); no geographic pattern was identified. *P. malariae*(n = 17) exhibited three different type of sequences, one for African and American isolates and the other two for the south-east Asian isolate and reference strain respectively. Those variations resulted in the same amino acid sequence (named M).

*P. ovale*(n = 13) exhibited three different types of nucleotide sequences, leading to three different types of amino acid sequences (named O1, O2 and O3). *P. berghei*and *P. yoeli*sequences exhibited synonymous mutations (named Y). *P. chabaudi*exhibited a nucleotide sequence (named C).*P. reichnowi*and *P. falciparum*sequences exhibited synonymous mutations.

Interestingly a comparison of the sequences of different species reveals the existence of conserved regions and other very variable ones; this inter-specific variation is exhibited in Figure [2](#F2){ref-type="fig"}. Table [2](#T2){ref-type="table"} gives details of the analysed isolates.

![Schematic representation of the 181 amino acid sequence variation (each different marks correspond to one amino acid change). F, F1, M, V, O1, O2, O, Y and C correspond to the sequence identified in the study (see result). The conserved regions of the *Plasmodium*pLDH gene for all species are highlighted in green.](1475-2875-6-140-2){#F2}

###### 

Result of the sequence analysis for the isolates tested in this paper.

  ID Code               Year   species   Origin                       Seq   AA
  --------------------- ------ --------- ---------------------------- ----- ----
  5353A                 2005   PF        South Africa                 F     F
  5353B                 2005   PF        South Africa                 F     F
  5421                  2005   PF        Benin                        F     F
  5445                  2005   PF        Brazil                       F     F
  4899                  2004   PF        Burkina Faso                 F     F
  CAMBF                 2001   PF        Cambodia                     F     F
  5203                  2005   PF        Cameroon                     F     F
  5848                  2005   PF        Cap Verde                    F     F
  5265                  2005   PF        Republic of Central Africa   F     F
  3414                  2002   PF        Colombia                     F     F
  4682                  2004   PF        Comoros                      F     F
  5405                  2005   PF        Congo                        F     F
  4919                  2004   PF        Ivory Cost                   F     F
  5600                  2005   PF        Dominican Republic           F     F
  1628                  1999   PF        Ecuador                      F     F
  5648                  2005   PF        Gabon                        F     F
  5083                  2004   PF        Gambia                       F     F
  5094                  2004   PF        Ghana                        F     F
  5898                  2005   PF        Guinea                       F     F
  5339                  2005   PF        Equatorial Guinea            F     F
  FguyF                 2003   PF        French Guiana                F     F
  5555                  2005   PF        Haiti                        F     F
  5745                  2005   PF        India                        F     F
  2038                  2000   PF        Kenya                        F     F
  4548                  2004   PF        Liberia                      F     F
  4609                  2004   PF        Madagascar                   F     F
  2686                  2001   PF        Malaysia                     F     F
  5296                  2005   PF        Malawi                       F     F
  5173                  2004   PF        Mali                         F     F
  5793                  2005   PF        Mali                         F     F
  4807                  2004   PF        Mauritania                   F     F
  4629                  2004   PF        Mozambique                   F     F
  5323                  2005   PF        Namibia                      F     F
  5822                  2005   PF        Niger                        F     F
  4582                  2004   PF        Nigeria                      F     F
  5846                  2005   PF        Pakistan                     F     F
  1317                  1998   PF        Papua New Guinea             F     F
  5225                  2005   PF        Sao Tome                     F     F
  4838A                 2004   PF        Senegal                      F     F
  4512                  2004   PF        Sierra Leone                 F     F
  4764                  2004   PF        Sir Lanka                    F     F
  4562                  2004   PF        Sudan                        F     F
  5224                  2005   PF        Tanzania                     F     F
  5647                  2005   PF        Chad                         F     F
  604                   1997   PF        Thailand                     F     F
  4751A                 2004   PF        Togo                         F     F
  4751B                 2004   PF        Togo                         F     F
  542                   1997   PF        Yemen                        F     F
  5197                  2005   PF        Congo Democratic Republic    F     F
  ID Code               Year   species   Origin                       Seq   AA
  Plasmodium malariae                                                       
  CAMBM                 2001   PM        Cambodia                     M2    M
  3413                  2002   PM        Cameroon                     M3    M
  4739                  2004   PM        Cameroon                     M3    M
  5990                  2006   PM        Cameroon                     M3    M
  1909                  1999   PM        Republic of Central Africa   M3    M
  3670                  2002   PM        Comoros                      M3    M
  4014                  2003   PM        Comoros                      M3    M
  1548                  1999   PM        Congo                        M3    M
  2667                  2001   PM        Ivory Cost                   M3    M
  5041                  2004   PM        Ivory Cost                   M3    M
  4568                  2004   PM        French Guiana                M3    M
  4774                  2004   PM        Madagascar                   M3    M
  516                   1997   PM        Senegal                      M3    M
  1018                  1998   PM        Togo                         M3    M
  2389                  2000   PM        Congo Democratic Republic    M3    M
  Plasmodium ovale                                                          
  5894                  2005   PO        Angola                       O2    O2
  CAMBO                 2001   PO        Cambodia                     O2    O2
  3044                  2001   PO        Republic of Central Africa   O2    O2
  5979                  2006   PO        Ivory Cost                   O2    O2
  3149                  2002   PO        Gabon                        O2    O2
  4646                  2004   PO        Guinea                       O2    O2
  3740                  2002   PO        Congo Democratic Republic    O2    O2
  4419                  2003   PO        Cameroon                     O3    O3
  5401                  2005   PO        Madagascar                   O3    O3
  2132                  2000   PO        Mali                         O3    O3
  5994                  2006   PO        Mali                         O3    O3
  2668                  2001   PO        Rwanda                       O3    O3
  3043                  2001   PO        Zimbabwe                     O3    O3
  Plasmodium vivax                                                          
  3019                  2001   PV        French Guiana                V1    V
  1977                  2000   PV        India                        V1    V
  1866                  1999   PV        Nicaragua                    V1    V
  800                   1997   PV        Thailand                     V1    V
  2642                  2001   PV        Madagascar                   V2    V
  5315                  2005   PV        Chine                        V3    V
  CAMBV                 2001   PV        Cambodia                     V4    V
  5753                  2005   PV        Comoros                      V4    V
  1173                  1998   PV        Laos                         V4    V
                                                                            
  ID Code                      species   Origin                       Seq   AA
  Reference strains                                                         
  3D7                          PF        pf13_0141                    F     F
  FCC1/HN                      PF        dq825436                     F1    F
  EMBL                         PM        ay486059                     M1    M
  EMBL                         PO        ay486058                     O1    O1
  EMBL                         PV        ay486060                     V1    V
                                                                            
  YOELII                       PY        xm_719008                    Y     Y
  CHABAUDI                     PC        xm_740087                    C     C
  BERGHEI                      PB        ay437808                     B     Y
  REICHNOWII                   PR        ab122147                     R     F

Seq = Nucleotide sequence, AA = aminoacid sequence

Discussion
==========

Here is described, for the first time, the sequence variability of pLDH in the four human\'s species of malaria and four animal *Plasmodium*species and analysed them together with published sequences. The results indicate the existence of both variable and conserved regions in plasmodial lactate dehydrogenase.

The intra-specific geographic conservation of pLDH suggests that genetic variability may not be linked to disparities in sensitivities or specificities observed in the detection of *P. falciparum*\[[@B3]\] with anti-pan LDH antibodies. The *falciparum*-specific epitope detected by RDTs is probably situated in the inter-specific variable regions we have identified; whilst the pan-malarial epitope is more likely situated in a conserved region. However, Moody *et al*. \[[@B2]\] reported that one pan-specific monoclonal antibody used in a pLDH RDT has a lower affinity to *P. malariae*and *P. ovale*antigens, the attribution of this to a sequence divergence must not be neglected and should be further investigated.

Conclusion
==========

The WHO states: \"Rapid diagnostic tests (RDTs) offer the potential to provide accurate diagnosis to all at risk populations (\...) The success of RDTs in malaria control will depend on good quality planning and implementation\" \[[@B9]\]. Moreover a rapid diagnostic test needs to be reliable globally, to detect an antigen that mirrors accurately blood parasitaemia; therefore part of a good quality assurance is to monitor such factors.

As part of this quality assurance, we have identified that an intra-specific genetic variability is not a significant factor in the variation of efficiency observed in rapid diagnostic tests in the detection of *P. falciparum*, *P vivax*and *P. malariae*, although it may explain the poor sensitivity to *P. ovale*\[[@B7]\]. Similar findings of low variability have been demonstrated for plasmodial aldolase another target antigen of MRDTs \[[@B10]\] despite a bad sensitivity in the dectection of *P. ovale*infection \[[@B11]\] in contrast to HRP2, a target antigen of *P. falciparum*with high variability affecting MRDT sensitivity. In this regard, pLDH offers advantages as a target antigen for diagnosis. The identification of pan-specific and species-specific regions may help in development of more sensitive and specific monoclonal antibodies for MRDTs.
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